The live webcast, which will include presentation slides, may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus’ website for 60 ...

Corvus Robotics , a leader in deploying physical AI robotic systems for logistics and warehousing operations, today announced ...

As of Thursday, January 08, Corvus Pharmaceuticals, Inc.’s CRVS share price has dipped by 6.45%, which has investors ...

Every investor in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion's share in the ...

Shares of Corvus Pharmaceuticals, Inc. (CRVS) traded 30% higher on Friday afternoon after Oppenheimer raised its price target on the stock to $17 from $15, while keeping an ‘Outperform’ rating on the ...

SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced new interim data from the ...

The cyber insurance industry is likely to go mainstream and is a simple cost of doing business. Here are a few options to consider. Read now Corvus Insurance, a company focused on applying artificial ...

BOSTON--(BUSINESS WIRE)--Corvus Insurance, the leading cyber underwriter, powered by a proprietary AI-driven cyber risk platform, announced today the launch of a new program with Core Specialty to ...

Carey said: "I am delighted to join Corvus after a fantastic 18 months at Embla. It’s an incredibly exciting time for Atlantic and I can’t wait to work with the fantastic team to find and publish more ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled ...